ArticleOncology reports2026

Knockdown of CCT2 inhibits the malignant progression of hepatocellular carcinoma cells by impairing STAT3 activation.

Chao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.